Intensive Care Medicine

, Volume 45, Issue 2, pp 249–251 | Cite as

What’s new in the prevention of healthcare-associated infections using chlorhexidine gluconate-impregnated washcloths

  • Sandrine Dray
  • Jean-Marie Forel
  • Laurent PapazianEmail author
What's New in Intensive Care

Critically ill patients hospitalized in intensive care units (ICUs) are at high risk for health care-associated infections (HAIs) in relation to their underlying conditions, comorbidities, impaired host defences, and the placement of invasive devices (endotracheal tubes, bladder catheters, and intravascular devices including catheters). These HAIs include surgical site infections, central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonias (VAPs), and bloodstream infections. HAIs are strongly associated with prolonged length of stay, increased mortality and increased costs. In addition, the number of infections related to multidrug resistant organisms (MDROs) is increasing and is associated with a limited number of effective antimicrobial drugs. Many of these organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae colonize the skin of hospitalized patients.



Compliance with ethical standards

Conflicts of interest

No conflict of interests.


  1. 1.
    Ruiz J, Ramirez P, Villarreal E, Gordon M, Saez I, Rodriguez A, Castaneda MJ, Castellanos-Ortega A (2017) Daily bathing strategies and cross-transmission of multidrug-resistant organisms: impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit. Am J Infect Control 45:1069–1073CrossRefGoogle Scholar
  2. 2.
    Lin MY, Lolans K, Blom DW, Lyles RD, Weiner S, Poluru KB, Moore N, Hines DW, Weinstein RA, Hayden MK, Centers for Disease C, Prevention Epicenter P (2014) The effectiveness of routine daily chlorhexidine gluconate bathing in reducing klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol 35:440–442CrossRefGoogle Scholar
  3. 3.
    Edmiston CE Jr, Seabrook GR, Johnson CP, Paulson DS, Beausoleil CM (2007) Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 35:89–96CrossRefGoogle Scholar
  4. 4.
    Rhee Y, Palmer LJ, Okamoto K, Gemunden S, Hammouda K, Kemble SK, Lin MY, Lolans K, Fogg L, Guanaga D, Yokoe DS, Weinstein RA, Frendl G, Hayden MK, Centers for Disease C, Prevention Epicenter P (2018) Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery. Infect Control Hosp Epidemiol 39:405–411CrossRefGoogle Scholar
  5. 5.
    Cassir N, Papazian L, Fournier PE, Raoult D, La Scola B (2015) Insights into bacterial colonization of intensive care patients’ skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 34:999–1004CrossRefGoogle Scholar
  6. 6.
    Cassir N, Thomas G, Hraiech S, Brunet J, Fournier PE, La Scola B, Papazian L (2015) Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control 43:640–643CrossRefGoogle Scholar
  7. 7.
    Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA (2007) Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167:2073–2079CrossRefGoogle Scholar
  8. 8.
    Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542CrossRefGoogle Scholar
  9. 9.
    Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R, Program CDCPE, Network AD, Healthcare-Associated Infections P (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265CrossRefGoogle Scholar
  10. 10.
    Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM, Pediatric STSG (2013) Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 381:1099–1106CrossRefGoogle Scholar
  11. 11.
    Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, Wheeler AP (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313:369–378CrossRefGoogle Scholar
  12. 12.
    Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec’h C, Azoulay E, Souweine B, Timsit JF, Group* OS (2017) Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect 74:131–141CrossRefGoogle Scholar
  13. 13.
    La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jaureguy F, Clec’h C, Decre D, Maury E, Dreyfuss D, Denamur E, Ricard JD (2018) Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients. Intensive Care Med 44:531–533CrossRefGoogle Scholar
  14. 14.
    Marolf CT, Alter R, Lyden E, Fey PD, Rupp ME (2017) Susceptibility of nosocomial staphylococcus aureus to chlorhexidine after implementation of a hospital-wide antiseptic bathing regimen. Infect Control Hosp Epidemiol 38:873–875CrossRefGoogle Scholar
  15. 15.
    Deeren D, Dewulf E, Verfaillie L (2016) Daily chlorhexidine bathing does not increase skin toxicity after remission induction or stem cell transplantation. Acta Clin Belg 71:379–382CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018

Authors and Affiliations

  • Sandrine Dray
    • 1
  • Jean-Marie Forel
    • 1
  • Laurent Papazian
    • 1
    Email author
  1. 1.Centre d’Etudes et de Recherches sur les Services de Santé et qualité de vie EA3279; APHM, Hôpital Nord, Médecine Intensive-RéanimationAix-Marseille UniversitéMarseilleFrance

Personalised recommendations